Bismuth-Containing Quadruple Therapy

DRUG3 trials

Sponsors

Takeda, Peking University First Hospital

Conditions

Duodenal UlcerGastric UlcerHelicobacter Pylori Infection

Phase 3

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection

CompletedNCT03050359

TakedaDuodenal Ulcer

Start: 2017-04-05End: 2019-07-19Updated: 2020-06-12

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection

CompletedNCT03050307

TakedaGastric Ulcer

Start: 2017-04-17End: 2020-05-26Updated: 2021-06-18

Unknown Phase

Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection

Peking University First HospitalHelicobacter Pylori Infection

Start: 2022-06-20End: 2024-12-31Target: 80Updated: 2022-10-18

Related Papers

Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of Helicobacter pylori in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials.

2024-01-014 citations